ProCE Banner Activity

Understanding BTK Inhibitor Resistance in CLL

Slideset

Review key data surrounding BTK inhibitor resistance in CLL, including optimal testing and treatment sequencing to overcome resistance to prior therapy. 

Released: October 01, 2024

Expiration: September 30, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca

AstraZeneca